NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive announced a quarterly dividend on Thursday, January 10th. Stockholders of record on Wednesday, January 23rd will be given a dividend of $0.42 per share on Friday, February 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend is Tuesday, January 22nd. View Colgate-Palmolive's Dividend History.

Colgate-Palmolive declared that its board has authorized a share buyback program on Monday, June 18th 2018, which authorizes the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday, October, 26th. The company reported $0.72 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.72. The business earned $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business's quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.73 EPS. View Colgate-Palmolive's Earnings History.

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January 25th 2019. View Earnings Estimates for Colgate-Palmolive.

Colgate-Palmolive will be holding an earnings conference call on Friday, January 25th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

16 equities research analysts have issued 12 month price objectives for Colgate-Palmolive's stock. Their predictions range from $54.00 to $79.00. On average, they anticipate Colgate-Palmolive's stock price to reach $66.7857 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

News articles about CL stock have trended somewhat negative on Thursday, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Colgate-Palmolive earned a news impact score of -1.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term.

Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Coty (COTY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Revlon (REV), Mandom (MDOMF), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).

Colgate-Palmolive's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.18%), Packer & Co Ltd (0.14%), LGT Capital Partners LTD. (0.11%), Gateway Investment Advisers LLC (0.09%), Douglass Winthrop Advisors LLC (0.06%) and Personal Capital Advisors Corp (0.06%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, Bath Savings Trust Co, Boston Advisors LLC, Bristlecone Advisors LLC, DNB Asset Management AS, Personal Capital Advisors Corp, Private Asset Management Inc. and Douglass Winthrop Advisors LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive.

CL stock was purchased by a variety of institutional investors in the last quarter, including Packer & Co Ltd, USS Investment Management Ltd, Rockland Trust Co., Bright Rock Capital Management LLC, Virtu Financial LLC, Deane Retirement Strategies Inc., Confluence Investment Management LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CL stock can currently be purchased for approximately $62.13.

Colgate-Palmolive has a market capitalization of $53.96 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.

The official website for Colgate-Palmolive is http://www.colgate.com/en-us/en/us/oc.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]